本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Tevogen Bio Holdings

4.46
-0.0200-0.45%
盤後4.460.00000.00%16:04 EDT
成交量:1.80萬
成交額:7.77萬
市值:1,857.24萬
市盈率:-0.55
高:4.46
開:4.37
低:4.20
收:4.48
52周最高:75.50
52周最低:4.14
股本:416.42萬
流通股本:113.30萬
量比:0.51
換手率:1.59%
股息:- -
股息率:- -
每股收益(TTM):-8.0804
每股收益(LYR):-3.5022
淨資產收益率:--
總資產收益率:-416.53%
市淨率:-1.09
市盈率(LYR):-1.27

資料載入中...

2025/04/18

重要事件披露

Form 8-K - Current report
2025/04/03

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/28

重要事件披露

Form 8-K - Current report
2024/11/19

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/26

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/08/23

重要事件披露

Form 8-K - Current report
2024/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/01

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/08/01

SEC問詢函

Form CORRESP - Correspondence
2024/07/31

SEC問詢函

Form CORRESP - Correspondence
2024/07/29

SEC問詢函

Form CORRESP - Correspondence
2024/07/23

SEC問詢函

Form CORRESP - Correspondence
2024/07/23

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/06/22

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/06/22

重要事件披露

Form 8-K - Current report
2024/06/11

重要事件披露

Form 8-K - Current report
2024/06/08

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/30

重要事件披露

Form 8-K/A - Current report: [Amend]